Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07840651 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Integrating Tuberculosis Treatment Into Community Pharmacies to Improve TB/HIV Outcomes in Uganda

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Community pharmacies (CPs) have emerged as promising differentiated service delivery models for refilling antiretroviral therapy (ART) among people with human immunodeficiency virus (HIV). Documented benefits of CP-based refills include improved treatment adherence and viral suppression, reduced healthcare provider workload, and reduced facility congestion. This trial will evaluate the acceptability, feasibility, fidelity, and preliminary effectiveness of integrating TB treatment into CPs among people with TB/HIV in Kampala, Uganda.
Trial Details
NCT Number NCT07840651
Lead Sponsor Makerere University
Collaborators: Fogarty International Center of the National Institute of Health
Conditions
(from sponsor)		 TB - Tuberculosis, HIV - Human Immunodeficiency Virus
Related terms Acquired Immunodeficiency Syndrome, Latent Tuberculosis, Tuberculosis
Enrollment 124 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov